{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:47:13Z","timestamp":1791121633825,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T00:00:00Z","timestamp":1336694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00535-012-0605-0","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T08:13:30Z","timestamp":1336637610000},"page":"1298-1307","source":"Crossref","is-referenced-by-count":148,"title":["Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn\u2019s disease"],"prefix":"10.1007","volume":"47","author":[{"given":"Akira","family":"Andoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kuzuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihito","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Fujiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,11]]},"reference":[{"key":"605_CR1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00535-006-1995-7","volume":"42","author":"BE Sands","year":"2007","unstructured":"Sands BE. Inflammatory bowel disease: past, present, and future. J Gastroenterol. 2007;42:16\u201325.","journal-title":"J Gastroenterol"},{"key":"605_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00535-009-0138-3","volume":"45","author":"L Mayer","year":"2010","unstructured":"Mayer L. Evolving paradigms in the pathogenesis of IBD. J Gastroenterol. 2010;45:9\u201316.","journal-title":"J Gastroenterol"},{"key":"605_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00535-005-1744-3","volume":"41","author":"T Hibi","year":"2006","unstructured":"Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol. 2006;41:10\u20136.","journal-title":"J Gastroenterol"},{"key":"605_CR4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417\u201329.","journal-title":"N Engl J Med"},{"key":"605_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-011-0521-8","volume":"47","author":"MJ Hamilton","year":"2012","unstructured":"Hamilton MJ, Snapper SB, Blumberg RS. Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance. J Gastroenterol. 2012;47:1\u20138.","journal-title":"J Gastroenterol"},{"key":"605_CR6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","volume":"134","author":"RB Sartor","year":"2008","unstructured":"Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577\u201394.","journal-title":"Gastroenterology"},{"key":"605_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-007-2111-3","volume":"43","author":"A Mizoguchi","year":"2008","unstructured":"Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol. 2008;43:1\u201317.","journal-title":"J Gastroenterol"},{"key":"605_CR8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","volume":"3","author":"RB Sartor","year":"2006","unstructured":"Sartor RB. Mechanisms of disease: pathogenesis of Crohn\u2019s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390\u2013407.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"605_CR9","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.addr.2007.07.003","volume":"59","author":"S Wirtz","year":"2007","unstructured":"Wirtz S, Neurath MF. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev. 2007;59:1073\u201383.","journal-title":"Adv Drug Deliv Rev"},{"key":"605_CR10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.pathol.1.110304.100128","volume":"2","author":"J Braun","year":"2007","unstructured":"Braun J, Wei B. Body traffic: ecology, genetics, and immunity in inflammatory bowel disease. Annu Rev Pathol. 2007;2:401\u201329.","journal-title":"Annu Rev Pathol"},{"issue":"Suppl 3","key":"605_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.03053.x","volume":"24","author":"P Seksik","year":"2006","unstructured":"Seksik P, Sokol H, Lepage P, Vasquez N, Manichanh C, Mangin I, et al. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24(Suppl 3):11\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"605_CR12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.0105-2896.2005.00291.x","volume":"206","author":"CO Elson","year":"2005","unstructured":"Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev. 2005;206:260\u201376.","journal-title":"Immunol Rev"},{"key":"605_CR13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature. 2001;411:603\u20136.","journal-title":"Nature"},{"key":"605_CR14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature07416","volume":"456","author":"K Cadwell","year":"2008","unstructured":"Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008;456:259\u201363.","journal-title":"Nature"},{"key":"605_CR15","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ibd.21868","volume":"18","author":"A Kabi","year":"2012","unstructured":"Kabi A, Nickerson KP, Homer CR, McDonald C. Digesting the genetics of inflammatory bowel disease: Insights from studies of autophagy risk genes. Inflamm Bowel Dis. 2012;18:782\u201392.","journal-title":"Inflamm Bowel Dis"},{"key":"605_CR16","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104:13780\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"605_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1440-1746.2000.02045.x","volume":"15","author":"H Matsuda","year":"2000","unstructured":"Matsuda H, Fujiyama Y, Andoh A, Ushijima T, Kajinami T, Bamba T. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J Gastroenterol Hepatol. 2000;15:61\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"605_CR18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1099\/jmm.0.46198-0","volume":"55","author":"K Lucke","year":"2006","unstructured":"Lucke K, Miehlke S, Jacobs E, Schuppler M. Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J Med Microbiol. 2006;55:617\u201324.","journal-title":"J Med Microbiol"},{"key":"605_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/gast.2002.30294","volume":"122","author":"A Swidsinski","year":"2002","unstructured":"Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44\u201354.","journal-title":"Gastroenterology"},{"key":"605_CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1348-0421.2002.tb02731.x","volume":"46","author":"H Hayashi","year":"2002","unstructured":"Hayashi H, Sakamoto M, Benno Y. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol. 2002;46:535\u201348.","journal-title":"Microbiol Immunol"},{"key":"605_CR21","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1128\/AEM.61.8.3069-3075.1995","volume":"61","author":"PS Langendijk","year":"1995","unstructured":"Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MH, et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol. 1995;61:3069\u201375.","journal-title":"Appl Environ Microbiol"},{"key":"605_CR22","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2174\/138161209788489186","volume":"15","author":"A Andoh","year":"2009","unstructured":"Andoh A, Benno Y, Kanauchi O, Fujiyama Y. Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease. Curr Pharm Des. 2009;15:2066\u201373.","journal-title":"Curr Pharm Des"},{"key":"605_CR23","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ibd.21866","volume":"18","author":"NA Nagalingam","year":"2012","unstructured":"Nagalingam NA, Lynch SV. Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2012;18:968\u201384.","journal-title":"Inflamm Bowel Dis"},{"key":"605_CR24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00535-010-0368-4","volume":"46","author":"A Andoh","year":"2011","unstructured":"Andoh A, Imaeda H, Aomatsu T, Inatomi O, Bamba S, Sasaki M, et al. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn\u2019s disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol. 2011;46:479\u201386.","journal-title":"J Gastroenterol"},{"key":"605_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2036.2008.03860.x","volume":"29","author":"A Andoh","year":"2009","unstructured":"Andoh A, Tsujikawa T, Sasaki M, Mitsuyama K, Suzuki Y, Matsui T, et al. Fecal microbiota profile of Crohn\u2019s disease determined by terminal restriction fragment length polymorphism (t-rflp) analysis. Aliment Pharmacol Ther. 2009;29:75\u201382.","journal-title":"Aliment Pharmacol Ther"},{"key":"605_CR26","doi-asserted-by":"crossref","first-page":"14691","DOI":"10.1073\/pnas.1005963107","volume":"107","author":"C Filippo De","year":"2010","unstructured":"De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107:14691\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"605_CR27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn\u2019s disease activity index National Cooperative Crohn\u2019s Disease Study. Gastroenterology. 1976;70:439\u201344.","journal-title":"Gastroenterology"},{"key":"605_CR28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.mimet.2004.12.009","volume":"61","author":"M Matsumoto","year":"2005","unstructured":"Matsumoto M, Sakamoto M, Hayashi H, Benno Y. Novel phylogenetic assignment database for terminal-restriction fragment length polymorphism analysis of human colonic microbiota. J Microbiol Methods. 2005;61:305\u201319.","journal-title":"J Microbiol Methods"},{"key":"605_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1099\/jmm.0.04991-0","volume":"52","author":"M Sakamoto","year":"2003","unstructured":"Sakamoto M, Takeuchi Y, Umeda M, Ishikawa I, Benno Y. Application of terminal RFLP analysis to characterize oral bacterial flora in saliva of healthy subjects and patients with periodontitis. J Med Microbiol. 2003;52:79\u201389.","journal-title":"J Med Microbiol"},{"key":"605_CR30","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/AEM.66.8.3616-3620.2000","volume":"66","author":"TL Marsh","year":"2000","unstructured":"Marsh TL, Saxman P, Cole J, Tiedje J. Terminal restriction fragment length polymorphism analysis program, a web-based research tool for microbial community analysis. Appl Environ Microbiol. 2000;66:3616\u201320.","journal-title":"Appl Environ Microbiol"},{"key":"605_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6941.2003.tb01040.x","volume":"43","author":"TC Hill","year":"2003","unstructured":"Hill TC, Walsh KA, Harris JA, Moffett BF. Using ecological diversity measures with bacterial communities. FEMS Microbiol Ecol. 2003;43:1\u201311.","journal-title":"FEMS Microbiol Ecol"},{"key":"605_CR32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jjco\/hyp188","volume":"40","author":"JK Chiang","year":"2010","unstructured":"Chiang JK, Cheng YH, Koo M, Kao YH, Chen CY. A computer-assisted model for predicting probability of dying within 7\u00a0days of hospice admission in patients with terminal cancer. Jpn J Clin Oncol. 2010;40:449\u201355.","journal-title":"Jpn J Clin Oncol"},{"key":"605_CR33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ibd.20151","volume":"13","author":"A Andoh","year":"2007","unstructured":"Andoh A, Sakata S, Koizumi Y, Mitsuyama K, Fujiyama Y, Benno Y. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm Bowel Dis. 2007;13:955\u201362.","journal-title":"Inflamm Bowel Dis"},{"key":"605_CR34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/00365520802433231","volume":"44","author":"J Nishikawa","year":"2009","unstructured":"Nishikawa J, Kudo T, Sakata S, Benno Y, Sugiyama T. Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. Scand J Gastroenterol. 2009;44:180\u20136.","journal-title":"Scand J Gastroenterol"},{"key":"605_CR35","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2036.2005.02428.x","volume":"21","author":"T Nomura","year":"2005","unstructured":"Nomura T, Ohkusa T, Okayasu I, Yoshida T, Sakamoto M, Hayashi H, et al. Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy. Aliment Pharmacol Ther. 2005;21:1017\u201327.","journal-title":"Aliment Pharmacol Ther"},{"key":"605_CR36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2180-11-7","volume":"11","author":"AW Walker","year":"2011","unstructured":"Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011;11:7.","journal-title":"BMC Microbiol"},{"key":"605_CR37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00253-008-1565-4","volume":"80","author":"UM Schutte","year":"2008","unstructured":"Schutte UM, Abdo Z, Bent SJ, Shyu C, Williams CJ, Pierson JD, et al. Advances in the use of terminal restriction fragment length polymorphism (T-RFLP) analysis of 16S rRNA genes to characterize microbial communities. Appl Microbiol Biotechnol. 2008;80:365\u201380.","journal-title":"Appl Microbiol Biotechnol"},{"key":"605_CR38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/dnares\/dsm018","volume":"14","author":"K Kurokawa","year":"2007","unstructured":"Kurokawa K, Itoh T, Kuwahara T, Oshima K, Toh H, Toyoda A, et al. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 2007;14:169\u201381.","journal-title":"DNA Res"},{"key":"605_CR39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1473-3099(07)70211-6","volume":"7","author":"M Feller","year":"2007","unstructured":"Feller M, Huwiler K, Stephan R, Altpeter E, Shang A, Furrer H, et al. Mycobacterium avium subspecies paratuberculosis and Crohn\u2019s disease: a systematic review and meta-analysis. Lancet Infect Dis. 2007;7:607\u201313.","journal-title":"Lancet Infect Dis"},{"key":"605_CR40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOG.0b013e3280105a38","volume":"23","author":"N Barnich","year":"2007","unstructured":"Barnich N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli and Crohn\u2019s disease. Curr Opin Gastroenterol. 2007;23:16\u201320.","journal-title":"Curr Opin Gastroenterol"},{"key":"605_CR41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331:337\u201341.","journal-title":"Science"},{"key":"605_CR42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2008.08.009","volume":"29","author":"JA Hall","year":"2008","unstructured":"Hall JA, Bouladoux N, Sun CM, Wohlfert EA, Blank RB, Zhu Q, et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity. 2008;29:637\u201349.","journal-title":"Immunity"},{"key":"605_CR43","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105:16731\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"605_CR44","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/ibd.20903","volume":"15","author":"H Sokol","year":"2009","unstructured":"Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"605_CR45","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1099\/ijs.0.02241-0","volume":"52","author":"SH Duncan","year":"2002","unstructured":"Duncan SH, Hold GL, Harmsen HJ, Stewart CS, Flint HJ. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol. 2002;52:2141\u20136.","journal-title":"Int J Syst Evol Microbiol"},{"key":"605_CR46","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022\u20133.","journal-title":"Nature"},{"key":"605_CR47","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2036.2011.04805.x","volume":"34","author":"T Aomatsu","year":"2011","unstructured":"Aomatsu T, Imaeda H, Matsumoto K, Kimura E, Yoden A, Tamai H, et al. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease. Aliment Pharmacol Ther. 2011;34:941\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"605_CR48","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1007\/s10620-011-1633-y","volume":"56","author":"T Aomatsu","year":"2011","unstructured":"Aomatsu T, Yoden A, Matsumoto K, Kimura E, Inoue K, Andoh A, et al. Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease. Dig Dis Sci. 2011;56:2372\u20137.","journal-title":"Dig Dis Sci"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-012-0605-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-012-0605-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-012-0605-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T11:20:38Z","timestamp":1594120838000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-012-0605-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,11]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1007\/s00535-012-0605-0","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,11]]}}}